ABOUT THIS EVENT

Cerevel Therapeutics (Nasdaq: CERE), a company dedicated to unravelling the mysteries of the brain to treat neuroscience diseases, rings the Nasdaq Closing Bell remotely from across the country.

In celebration of its IPO, Tony Coles, M.D., Chairperson of the Board of Directors & CEO, rings the Closing Bell alongside members of the Company’s team in a virtual bell ringing ceremony.